Euro
USD
British Pound
NULL
Product Description
EBAG9 Peptide | 45-515P | ProSci
Short Description: EBAG9 / RCAS1 Peptide
Species: Human
Location: EBAG9 peptide corresponds to 12 amino acids of EBAG9.
Tested Application: Bl
Application: EBAG9 Peptide is used for blocking the activity of EBAG9 antibody (catalog number 45-515). The EBAG9 antibody ships at 0.5 mg/mL and the EBAG9 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
Physical State: Lyophilized
Buffer: EBAG9 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.
Concentration: N/A
Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.
NCBI Official Symbol: EBAG9
Alternate Names: EB9, PDAF, RCAS1, Receptor-binding cancer antigen expressed on SiSo cells, Cancer-associated surface antigen RCAS1,
NCBI Gene ID: 9166
User Note: N/A
NCBI Official Name: Estrogen Receptor Binding Site Associated, Antigen, 9
Background: N/A
Disclaimer: This product is for research use only.
